News Releases
Search
August 9, 2022
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2022 Financial Results
June 16, 2022
Cogent Biosciences Announces Closing of Upsized Public Offering of Common Stock and Pre-funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 13, 2022
Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock and Pre-funded Warrants
June 13, 2022
Cogent Biosciences Announces Proposed Public Offering of Common Stock
June 10, 2022
Cogent Biosciences Announces Positive Initial Clinical Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
June 6, 2022
Cogent Biosciences to Host Investor Webcast on June 10, 2022 at 8:00am ET
June 2, 2022
Cogent Biosciences Announces Annual Meeting of Stockholders
May 12, 2022
Cogent Biosciences Announces Presentation at European Hematology Association (EHA) Annual Congress
May 10, 2022
Cogent Biosciences Reports Recent Business Highlights and First Quarter 2022 Financial Results
May 6, 2022
Cogent Biosciences to Participate in the LifeSci Partners Immunology and Inflammation Symposium
Displaying 1 - 10 of 16
The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Unum disavows any obligation to update the information contained in such press releases after the date of their issuance.